uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro from cytotoxic synergy to complete inhibition of apoptosis.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Cancer Pharmacology and Informatics)
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Cancer Pharmacology and Informatics)
Department of Oncology, Radiology and Clinical Immunology. (Cancer Pharmacology and Informatics)
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Cancer Pharmacology and Informatics)
2002 (English)In: Br J Pharmacol, Vol. 137, 568- p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2002. Vol. 137, 568- p.
Identifiers
URN: urn:nbn:se:uu:diva-64595OAI: oai:DiVA.org:uu-64595DiVA: diva2:92506
Available from: 2007-02-08 Created: 2007-02-08 Last updated: 2011-01-13

Open Access in DiVA

No full text

Authority records BETA

Nygren, PeterLarsson, Rolf

Search in DiVA

By author/editor
Nygren, PeterLarsson, Rolf
By organisation
Department of Medical SciencesDepartment of Oncology, Radiology and Clinical Immunology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 597 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf